Article: Patients With Acute Musculoskeletal Spasm Experience Significant Improvement In Physical Functioning With Flexeril 5 Mg; Physical Functioning Is an Important Measure to Consider in Evaluating the Overall Outcome of Patients With Acute Musculoskeletal Spasm Suggest Researchers.

ORLANDO, Fla., Oct. 27 /PRNewswire/ -- Patients suffering from acute musculoskeletal spasm of the back and neck who were treated with FLEXERIL(R) (cyclobenzaprine HCl) 5 mg tablets reported statistically significant improvement in physical functioning (discomfort on motion) versus patients on placebo, and similar improvement in physical functioning experienced by patients taking the older 10 mg version of the medication, according to new research presented at the Annual Scientific meeting of the American College of Rheumatology.

Previously published data demonstrates that the 5 mg and 10 mg strengths of FLEXERIL are comparable in their ability to provide ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!